Pharmacologic profiling reveals lapatinib as a novel antiviral against SARS-CoV-2 in vitro. Raymonda MH, Ciesla JH, Monaghan M, Leach J, et al. Virology 2022;566:60-68.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Raymonda MH, Ciesla JH, Monaghan M, Leach J, et al. Pharmacologic profiling reveals lapatinib as a novel antiviral against SARS-CoV-2 in vitro. Virology 2022;566:60-68.
PMID: 34871905